You’ve probably heard of Ozempic by now. The once-a-week injection first developed to treat type 2 diabetes is now a global headline-maker, thanks to its striking impact on appetite, cravings and body weight. From the red carpets of Hollywood to NHS clinics across the UK, this new class of medicines , known as GLP-1 receptor agonists, is rapidly changing the way we approach obesity. But while most people are aware of Ozempic’s effects on hunger and weight loss, there’s another, less expected shift taking place for many patients: the taste of food itself begins to change. For some, rich meals become less appealing, sweet treats lose their shine, and once-irresistible cravings simply melt away. So, is it real? And if so, why is it happening?

HELLO! spoke to leading medical experts an

See Full Page